However, sometimes improvements to user experience come from combining devices with digital technologies, such as smartphone apps, without changing the injection device itself
Essential monitoring requirements include: HbA1c levels : Typically checked every 36 months to assess glycaemic control Renal function : eGFR and serum creatinine monitored regularly (at least annually, more frequently if borderline) Body weight : Both medications may promote weight loss Blood pressure : Monitor for hypotension, especially initially Ketone testing : If you feel unwell, particularly with vomiting or abdominal pain Eye examinations : Regular diabetic retinopathy screening Your GP or diabetes nurse will establish an appropriate monitoring schedule
However, individuals who have type 2 diabetes alongside a need to minimise weight gain or promote weight loss may benefit from GLP-1/GIP therapy and its dual impact on type 2 diabetes management and weight loss
Nhng chic l ny cha nhiu hp cht c kh nng hot tnh sinh hc, bao gm mt s loi flavonoid v terpenoid
Updated April 16, 2025
The graphic representation does not show a clear asymmetry (Supplementary Figure S1)